Use of E. coli Purine Nucleoside Phosphorylase in the Treatment of Solid Tumors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|45|7003-7024

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.45, 2018-02, pp. : 7003-7024

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of the enzyme purine nucleoside phosphorylase

By Morris Jr. P.E.   Montgomery J.A.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 3, 1998-03 ,pp. : 283-299

Informa Healthcare

Access to resources Recommend Favorite

Transition States and Inhibitors of the Purine Nucleoside Phosphorylase Family

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 13, 2005-10 ,pp. : 1237-1258

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of the Enzyme Purine Nucleoside Phosphorylase as Potential Therapy for Psoriasis

By  

Current Pharmaceutical Design, Vol. 6, Iss. 9, 2000-06 ,pp. : 943-959

Bentham Science Publishers

Access to resources Recommend Favorite

Purine Nucleoside Phosphorylase: A Potential Target for the Development of Drugs to Treat T-Cell- and Apicomplexan Parasite-Mediated Diseases

By  

Current Drug Targets, Vol. 8, Iss. 3, 2007-03 ,pp. : 413-422

Bentham Science Publishers

Access to resources Recommend Favorite

Purine Nucleoside Analogs in the Treatment of Rarer Chronic Lymphoid Leukemias

By  

Current Pharmaceutical Design, Vol. 18, Iss. 23, 2012-08 ,pp. : 3373-3388

Bentham Science Publishers

Access to resources Recommend Favorite